These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1710239)

  • 1. CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression.
    Risso A; Smilovich D; Capra MC; Baldissarro I; Yan G; Bargellesi A; Cosulich ME
    J Immunol; 1991 Jun; 146(12):4105-14. PubMed ID: 1710239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1.
    Tugores A; Alonso MA; Sánchez-Madrid F; de Landázuri MO
    J Immunol; 1992 Apr; 148(7):2300-6. PubMed ID: 1545132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell activation via Leu-23 (CD69).
    Testi R; Phillips JH; Lanier LL
    J Immunol; 1989 Aug; 143(4):1123-8. PubMed ID: 2501389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C.
    Testi R; Phillips JH; Lanier LL
    J Immunol; 1989 Mar; 142(6):1854-60. PubMed ID: 2466079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway.
    Santis AG; Campanero MR; Alonso JL; Tugores A; Alonso MA; Yagüe E; Pivel JP; Sánchez-Madrid F
    Eur J Immunol; 1992 May; 22(5):1253-9. PubMed ID: 1577066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28- T lymphocytes. Antigenic and functional properties.
    Azuma M; Phillips JH; Lanier LL
    J Immunol; 1993 Feb; 150(4):1147-59. PubMed ID: 8381831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
    Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
    J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the early lymphocyte activation antigen CD69, a C-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs.
    Santis AG; López-Cabrera M; Sánchez-Madrid F; Proudfoot N
    Eur J Immunol; 1995 Aug; 25(8):2142-6. PubMed ID: 7664776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes.
    Sidorenko SP; Clark EA
    J Immunol; 1993 Nov; 151(9):4614-24. PubMed ID: 8409422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals.
    Mardiney M; Brown MR; Fleisher TA
    Cytometry; 1996 Dec; 26(4):305-10. PubMed ID: 8979031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gp33-38, an early human T cell activation antigen.
    Carrel S; Salvi S; Isler P; Rapin C; Hayoz D; Gallay P; Giuffrè L
    J Immunol; 1990 Mar; 144(6):2053-62. PubMed ID: 2138192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.
    Nel AE; Hanekom C; Rheeder A; Williams K; Pollack S; Katz R; Landreth GE
    J Immunol; 1990 Apr; 144(7):2683-9. PubMed ID: 2156931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester.
    Bott CM; Doshi JB; Li LL; McMurtry SA; Sanders JL; Fox DA
    J Immunol; 1994 Jul; 153(1):1-9. PubMed ID: 8207228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. Effects of stimulation with soluble or immobilized CD3 antibodies.
    Manger B; Weiss A; Imboden J; Laing T; Stobo JD
    J Immunol; 1987 Oct; 139(8):2755-60. PubMed ID: 3116093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.